Difference between revisions of "Projects:fMRIAnalysisAnxietyDisorder"
From NAMIC Wiki
| Line 13: | Line 13: | ||
The study is currently in the recruitment phase. 30 PD with Agoraphobia, meeting criteria of DSM-IV, will be recruited from the Anxiety Disorder Clinic of the CAMH and 20 healthy control subjects recruited by means of a flyer. | The study is currently in the recruitment phase. 30 PD with Agoraphobia, meeting criteria of DSM-IV, will be recruited from the Anxiety Disorder Clinic of the CAMH and 20 healthy control subjects recruited by means of a flyer. | ||
| + | ''References'' | ||
'''Key Investigators''' | '''Key Investigators''' | ||
| − | * Claudia Rothe, Peter Soros, Simon Graham, James Kennedy | + | |
| + | * Toronto: Claudia Rothe, Peter Soros, Simon Graham, James Kennedy | ||
'''Links''' | '''Links''' | ||
| − | + | * http://www.vepsy.com; http://www.cybertherapy.info (VEPSY: Europe based project to develop virtual reality for treatment of anxiety disorders) | |
Revision as of 13:25, 4 September 2007
Home < Projects:fMRIAnalysisAnxietyDisorderfMRI Analysis Anxiety Disorder
Back to NA-MIC_Collaborations
Objectives
1. to explore how variants of candidate genes predict different fMRI activation patterns in selected brain regions in patients vs. controls when processing threatening stimuli 2. to combine autonomic measures, fMRI activation patterns and genetic variants reveal more specific subtypes of PD 3. to evaluate how repeated exposure to the threatening stimuli changes the fMRI pattern and possibly the electrophysiological response
Progress
The study is currently in the recruitment phase. 30 PD with Agoraphobia, meeting criteria of DSM-IV, will be recruited from the Anxiety Disorder Clinic of the CAMH and 20 healthy control subjects recruited by means of a flyer.
References
Key Investigators
- Toronto: Claudia Rothe, Peter Soros, Simon Graham, James Kennedy
Links
- http://www.vepsy.com; http://www.cybertherapy.info (VEPSY: Europe based project to develop virtual reality for treatment of anxiety disorders)
